Neoplasm Malignant

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients

A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

EMPOWER 3: Improving Palliative Care Health Literacy and Utilization

Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)